MLXIPL |
Molecular mechanism of glycolysis activated |
Marker exhibits malignant biological behavior by activating glycolysis |
[38] |
LncRNA HOXA-AS2 |
High expression |
Initiation and progression of HCC |
[19] |
CKS2, MIF, RPL12, HSP90AB1, and S100A6 |
High expression |
Overall survival rate decreased |
[39] |
CCL14, CD5L, and APOC3 |
Low expression |
Overall survival rate decreased |
[39] |
ZNF717 |
High-frequency mutation |
Tumor suppressor activity regulating IL-6/STAT3 pathway |
[40] |
IGF2 |
Over expression |
Growth regulation |
[41] |
Osteopontin |
Over expression |
Potentially regulate different immune cell types in TME; invasion and progression of HCC |
[42] |